Keywords: panel, split, orlistat, approval, obesity, roche, suffered

Panel Split On Orlistat Approval For Obesity

Article | 16 March 1998

Print This

Roche suffered a further setback in its bid to get US approval for itsnew obesity drug Xenical (orlistat) on March 13, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in